Testing effectiveness (Phase 2)Study completedNCT01141712What this trial is testingAutologous Transplant in HIV Patients (BMT CTN 0803)Who this might be right forLymphomaHIV Medical College of Wisconsin 43
Testing effectiveness (Phase 2)Study completedNCT00290472What this trial is testingCCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forB-cell Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueMalignant Neoplasm+15 more National Cancer Institute (NCI) 89
Testing effectiveness (Phase 2)Study completedNCT00440388What this trial is testingSafety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's LymphomaWho this might be right forFollicular Lymphoma Ascenta Therapeutics 23
Testing effectiveness (Phase 2)Ended earlyNCT00006478What this trial is testingVaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Nebraska 19
Testing effectiveness (Phase 2)WithdrawnNCT00006669What this trial is testingRituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's LymphomaWho this might be right forLymphoma Medstar Health Research Institute
Testing effectiveness (Phase 2)Study completedNCT00003397What this trial is testingPeripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Maryland, Baltimore 25
Testing effectiveness (Phase 2)Study completedNCT00093769What this trial is testingBortezomib and Rituximab in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Jonsson Comprehensive Cancer Center 15
Early research (Phase 1)Active Not RecruitingNCT01955499What this trial is testingLenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular LymphomaRecurrent Lymphoplasmacytic Lymphoma+7 more National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Study completedNCT00004107What this trial is testingRadiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's MacroglobulinemiaWho this might be right forLeukemiaLymphoma Garden State Cancer Center at the Center for Molecular Medicine and Immunology 18
Testing effectiveness (Phase 2)Study completedNCT02611323What this trial is testingObinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forNon-Hodgkin's Lymphoma Hoffmann-La Roche 133
Early research (Phase 1)Ended earlyNCT01643603What this trial is testingDasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesWho this might be right forNon-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more Barbara Ann Karmanos Cancer Institute 5
Not applicableStudy completedNCT03568929What this trial is testingSafety Profile of Idelalisib in Patients With Refractory Follicular LymphomaWho this might be right forFollicular Non-Hodgkin's Lymphoma Refractory Gilead Sciences 257
Early research (Phase 1)Study completedNCT02635672What this trial is testingPhase I Dose Escalation Study for VIP152 in Patients With Advanced CancerWho this might be right forNeoplasms Vincerx Pharma, Inc. 110
Not applicableWithdrawnNCT00110006What this trial is testingPositron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's LymphomaWho this might be right forLymphoma Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00073931What this trial is testingIodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Fred Hutchinson Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT00045877What this trial is testingProleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan TreatmentsWho this might be right forLymphoma, Non-Hodgkin Chiron Corporation
Not applicableNot Yet RecruitingNCT05923502What this trial is testing(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)Who this might be right forFollicular LymphomaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRichter Syndrome+3 more Ruijin Hospital 200
Large-scale testing (Phase 3)Study completedNCT00002649What this trial is testingInterleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's LymphomaWho this might be right forRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell Lymphoma+5 more National Cancer Institute (NCI) 206
Not applicableEnded earlyNCT05645744What this trial is testingLong-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.Who this might be right forBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Chronic Lymphocytic Leukemia in RelapseSmall Lymphocytic Lymphoma, Relapsed+8 more Mustang Bio 3
Large-scale testing (Phase 3)UnknownNCT00003924What this trial is testingInterferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaWho this might be right forLymphoma Lymphoma Study Association 360